These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 7640209)

  • 61. Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells.
    Berger W; Elbling L; Hauptmann E; Micksche M
    Int J Cancer; 1997 Sep; 73(1):84-93. PubMed ID: 9334814
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multidrug resistance related genes and p53 expression in human non small cell lung cancer.
    Galimberti S; Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bevilacqua G; Petrini M
    Anticancer Res; 1998; 18(4C):2973-6. PubMed ID: 9713494
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
    Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
    Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.
    Breuninger LM; Paul S; Gaughan K; Miki T; Chan A; Aaronson SA; Kruh GD
    Cancer Res; 1995 Nov; 55(22):5342-7. PubMed ID: 7585598
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
    Stein U; Walther W; Laurencot CM; Scheffer GL; Scheper RJ; Shoemaker RH
    J Natl Cancer Inst; 1997 Jun; 89(11):807-13. PubMed ID: 9182980
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.
    Nakamura T; Oka M; Aizawa K; Soda H; Fukuda M; Terashi K; Ikeda K; Mizuta Y; Noguchi Y; Kimura Y; Tsuruo T; Kohno S
    Biochem Biophys Res Commun; 1999 Feb; 255(3):618-24. PubMed ID: 10049760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line.
    Gaj CL; Anyanwutaku I; Chang YH; Cheng YC
    Biochem Pharmacol; 1998 Apr; 55(8):1199-211. PubMed ID: 9719474
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance.
    Yu DS; Ma CP; Chang SY
    Urol Res; 2000 Apr; 28(2):86-92. PubMed ID: 10850629
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential expression of multidrug resistance‑related proteins in adriamycin‑resistant (pumc‑91/ADM) and parental (pumc‑91) human bladder cancer cell lines.
    Zhao M; Yu S; Zhang M
    Mol Med Rep; 2016 Nov; 14(5):4741-4746. PubMed ID: 27748815
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA.
    Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH
    Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.
    Clifford SC; Neal DE; Lunec J
    Br J Cancer; 1996 Mar; 73(5):659-66. PubMed ID: 8605104
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype.
    Matsumoto Y; Takano H; Fojo T
    Cancer Res; 1997 Nov; 57(22):5086-92. PubMed ID: 9371507
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multidrug resistance in leukemias and its reversal.
    Malayeri R; Filipits M; Suchomel RW; Zöchbauer S; Lechner K; Pirker R
    Leuk Lymphoma; 1996 Nov; 23(5-6):451-8. PubMed ID: 9031075
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells.
    Ishikawa Y; Nagai J; Okada Y; Sato K; Yumoto R; Takano M
    Biol Pharm Bull; 2010; 33(3):504-11. PubMed ID: 20190417
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
    Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
    Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
    Gai XD; Li GL; Huang JZ; Xue HJ; Wang D
    Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells.
    Hu Y; Stephen AG; Cao J; Tanzer LR; Slapak CA; Harrison SD; Devanarayan V; Dantzig AH; Starling JJ; Rome LH; Moore RE
    Int J Cancer; 2002 Jan; 97(2):149-56. PubMed ID: 11774257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
    Kowalski P; Stein U; Scheffer GL; Lage H
    Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
    Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
    Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.